Vyripharm International, Inc. and the National Yang-Ming University Signed a MOU to Develop VYR-206 as a Novel Diagnostic Approach for Neurological Disorders Outcomes Following Treatments
HOUSTON--(BUSINESS WIRE)--Vyripharm International, Inc. (VI), is a subsidiary of Vyripharm Enterprises, LLC, a privately held…